Autism spectrum disorder (ASD) affects individuals worldwide, but it’s important to note that gathering precise global statistics on the prevalence of autism can be challenging due to various factors such as differences in diagnostic criteria, data collection methods, and cultural factors. However, estimates from reputable sources provide a general understanding of the global prevalence of autism:
According to the World Health Organization (WHO), globally, it is estimated that around 1 in 160 children has ASD. This estimate was based on data from studies conducted in high-income countries.
It’s important to note that these prevalence rates can vary across different countries and regions due to various factors, including differences in awareness, diagnostic practices, and access to services.
For the most accurate and up-to-date information on autism prevalence specific to a particular country or region, it is recommended to consult official government health agencies, autism advocacy organizations, or research institutions that specialize in autism research in that specific area.
Here find 5 important studies about CBD and Autism:
The therapeutic potential of cannabidiol (CBD), a non-psychoactive component of cannabis, has been increasingly recognized…
Recent research delves into the pharmacological landscape of GPR18, a G-protein-coupled receptor, and its activation…
Psoriasis, a chronic skin condition with no definitive cure, affects millions globally, creating a necessity…
Recent research has brought to light the potential of cannabidiol (CBD), a non-psychoactive component of…
Glioblastoma multiforme (GBM) is the most aggressive and common form of primary brain tumor in…
In a groundbreaking study published in the Frontiers in Pharmacology journal, researchers discovered that oral…